Delivery Order SPE2DB22D3301-SPE2DB25FY9BS
Award Date 8/8/25
Potential Completion Date 8/29/25
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $27,719.00 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials under a firm fixed-price contract structure. The award, issued on September 29, 2025, with an ultimate completion date of October 21, 2025, represents a non-competitive delivery against AmerisourceBergen's larger pharmaceutical supply agreement. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $11,087.60 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials. This competitively awarded, firm fixed price contract was executed on September 2, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical distributor will perform the delivery at its corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this award reflects AmerisourceBergen's continued...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.95 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $11,087.70 delivery order to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with performance to be completed by September 23, 2025. This competitively awarded, firm fixed-price contract is being executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $22,175.20 delivery order to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of October 20, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $8,315.70 to supply PADCEV 30 mg vials, a pharmaceutical product for oncology treatment. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 15, 2025, for Padcev 30 mg vials with a ceiling value of $83,157.00. This firm fixed price contract, issued by the Defense Logistics Agency's Medical Supply Chain, represents a competitively awarded procurement with no set-aside designation and is scheduled for completion by October 6, 2025. The contract is structured as a child delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of PADCEV 30 mg vials, a specialized pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $27.7K and is scheduled for completion by August 4, 2025. The contract was awarded competitively with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a competitively solicited delivery order valued at $7,391.80 for PADCEV (ado-trastuzumab vedotin) 20 mg vials by the Defense Logistics Agency's Medical Supply Chain on September 5, 2025, with a completion date of September 26, 2025. This firm fixed-price delivery order is not set aside and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. PADCEV is an antibody-drug conjugate used in oncology treatment, specifically...